EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

An Observational Study on Clinicopathological Characteristics and Correlation with Pathological Response in Patients Post-neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

Imaan Rumani, Jayanta Chakrabarti, Sandip Swarup Mandal, Souradip Gupta, Bilal Kazi, Koustav Majumder, Srabani Chakrabarti, Durga Prasad Nanda, Ratnadeep Paul

Journal of Current Oncological Trends · 2024

DOI: 10.4103/jcot.jcot_1_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Current Oncological Trends, 2024. Verfasst von Imaan Rumani und 8 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Locally advanced breast cancer, the most advanced stage of nonmetastatic breast cancer, has a substantial risk of recurrence, metastasis, and death, with a 5-year overall survival rate of approximately 57%. Aims and Objective: The aim of the study was to correlate and compare the clinical, radiological, and the pathological parameters in assessing the tumor response to neoadjuvant chemotherapy (NACT) and to assess rates of complete clinical and pathological response in patients of breast carcinoma being treated with NACT. Materials and Methods: This study was a prospective, nonrandomized, observational study. This study was conducted at Chittaranjan National Cancer Institute, Kolkata from January 2021 to January 2023 in the Department of Surgical Oncology. A total of 131 patients were included in this study.

Results

It was found that the majority of patients (51.1%) showed a complete pathological response in the lymph nodes with the maximum number of patients belonging to the basal-like subgroup (20); it was statistically significant ( P = 0.001). Higher number of patients had (57.1%) moderate residual disease (residual cancer burden [RCB1]) on final histopathology in luminal A type compared to (54.3%) luminal B type, (47.6%) basal like, and human epidermal growth receptor-2 enriched (31.0%), so correlation of molecular types and RCB was statistically significant ( P < 0.001).

Conclusion

From our study, we conclude that histopathological examination is the gold standard for assessing chemotherapeutic tumor response in breast carcinoma. Patients with molecular subtype HER2 neu and triple negative were good responders to chemotherapy. There was a reduction in the tumor size and an increase in clinically node-negative status following chemotherapy, indicating downstaging of the tumor in the majority of the patients after NACT. Neoadjuvant therapy can potentially make inoperable tumors operable. Patients who achieve a complete clinical response may not have a complete pathological response. The prognosis of the patient cannot be predicted depending on clinical response.

Zitieren

APA

Rumani, I., Chakrabarti, J., Mandal, S. S., Gupta, S., Kazi, B., Majumder, K., Chakrabarti, S., Nanda, D. P., & Paul, R. (2024). An Observational Study on Clinicopathological Characteristics and Correlation with Pathological Response in Patients Post-neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. Journal of Current Oncological Trends. https://doi.org/10.4103/jcot.jcot_1_24

Vancouver

Rumani I, Chakrabarti J, Mandal SS, Gupta S, Kazi B, Majumder K, et al. An Observational Study on Clinicopathological Characteristics and Correlation with Pathological Response in Patients Post-neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. Journal of Current Oncological Trends. 2024. doi:10.4103/jcot.jcot_1_24

BibTeX
@article{Rumani2024,
  author = {Rumani, Imaan and Chakrabarti, Jayanta and Mandal, Sandip Swarup and Gupta, Souradip and Kazi, Bilal and Majumder, Koustav and Chakrabarti, Srabani and Nanda, Durga Prasad and Paul, Ratnadeep},
  title = {An Observational Study on Clinicopathological Characteristics and Correlation with Pathological Response in Patients Post-neoadjuvant Chemotherapy in Locally Advanced Breast Cancer},
  journal = {Journal of Current Oncological Trends},
  year = {2024},
  doi = {10.4103/jcot.jcot_1_24}
}
Kostenlos starten →